You are here:Home-ADCs and PROTACs-PROTAC-YJ9069
YJ9069

Chemical Structure : YJ9069

CAS No.: 3053716-68-7

YJ9069 (YJ-9069)

Catalog No.: PC-23148Not For Human Use, Lab Use Only.

YJ9069 is a selective CDK12/13 PROTAC degrader, exhibits preferential cytotoxicity in multiple cancers.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
250 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

YJ9069 is a selective CDK12/13 PROTAC degrader, exhibits preferential cytotoxicity in multiple cancers.
YJ9069 effectively inhibited phosphorylation of RNA polymerase II at serine 2 in VCaP and 22Rv1 cells.
YJ9069 effectively inhibited cell growth as measured by IncuCyte in a dose-dependent manner while having no antiproliferative effect on benign or non-neoplastic prostate cells at parallel doses.
YJ9069 suppresses tumor growth in multiple in vivo prostate cancer models.

Physicochemical Properties

M.Wt 849.95
Formula C47H47N9O7
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

Urea, N-[4-[4-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]-1-piperazinyl]phenyl]-N′-(phenylmethyl)-N-[trans-4-(2-quinazolinylamino)cyclohexyl]-

References

1. Chang Y, et al. Cell Rep Med. 2024 Sep 21:101752. doi: 10.1016/j.xcrm.2024.101752.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: